Nordson Corp (NDSN) Stock Price & Analysis
Nordson Corp (NDSN) rose 2.81% to USD 290.13 as of June 10, 2026 at 00:50 UTC, according to Nexqual real-time market data.
NDSN last closed at USD 282.21; the session ranged USD 284.39–290.55 on volume of 367,048 shares. Market capitalization is $16.17B, with a 52-week range of USD 207.08–305.28 (NMS). Source: Nexqual, June 10, 2026 at 00:50 UTC.
Key Statistics (as of June 10, 2026 at 00:50 UTC)
| Price | USD 290.13 |
|---|---|
| Change | ▲ 2.81% (up) |
| Previous Close | USD 282.21 |
| Open | USD 285.11 |
| Day Range | USD 284.39 – 290.55 |
| 52-Week Range | USD 207.08 – 305.28 |
| Volume | 367,048 shares |
| Market Cap | $16.17B |
| Exchange | NMS |
Technical Analysis (NDSN)
Nexqual's technical model rates NDSN "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 00:50 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.52 (neutral) |
| vs SMA50 | Above (USD 279.9) |
| MACD | 1.76 (positive) |
Analyst Ratings (NDSN)
Wall Street analysts rate NDSN "Buy" based on 8 analysts, with a mean price target of USD 319.13 (range USD 260–345), per Nexqual as of June 10, 2026 at 00:50 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 8 |
| Mean Target | USD 319.13 |
| High Target | USD 345 |
| Low Target | USD 260 |
| Buy / Hold / Sell | 5 / 4 / 0 |
Earnings (NDSN)
| Next Earnings Date | 2026-08-19 |
|---|---|
| EPS Estimate | USD 3.06 |
| Revenue Estimate | $779.46M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-04-30 | USD 2.86 vs est 2.82 ▲ beat |
| 2026-01-31 | USD 2.37 vs est 2.37 ▼ miss |
| 2025-10-31 | USD 3.03 vs est 2.93 ▲ beat |
| 2025-07-31 | USD 2.73 vs est 2.64 ▲ beat |
Source: Nexqual, June 10, 2026 at 00:50 UTC.
Financials & Fundamentals (NDSN)
| Total Revenue | $2.90B |
|---|---|
| Revenue Growth (YoY) | +8.50% |
| Gross Margin | +55.22% |
| Operating Margin | +23.52% |
| Profit Margin | +18.19% |
| ROE | +17.14% |
| Debt / Equity | 61.64 |
| Current Ratio | 2.6 |
| Total Cash | $103.14M |
| Total Debt | $1.97B |
| Free Cash Flow | $574.59M |
Source: Nexqual, June 10, 2026 at 00:50 UTC.
Financial Health Score (NDSN)
Nexqual rates Nordson Corp's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 00:50 UTC.
| Growth | Mixed — Revenue +3.8% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 55%, operating 24% |
| Balance Sheet | Strong — $103M cash vs $1.97B debt |
| Cash Flow | Strong — FCF $575M, 21% margin |
| Efficiency | Solid — ROE 17%, ROA 7.9% |
Ownership (NDSN)
| Insider Ownership | +5.59% |
|---|---|
| Institutional Ownership | +77.13% |
| Shares Outstanding | 55.72M |
| Float | 49.65M |
| Short % of Float | +3.00% |
Source: Nexqual, June 10, 2026 at 00:50 UTC.
Leadership (NDSN)
Nordson Corp is led by Sundaram Nagarajan (age 62), President, CEO & Director, per Nexqual as of June 10, 2026 at 00:50 UTC.
| President, CEO & Director | Sundaram Nagarajan (age 62) |
|---|---|
| Executive VP & CFO | Daniel R. Hopgood (age 52) |
| Vice President of Investor Relations & Corporate Communications | Lara L. Mahoney |
| Vice President of Corporate Development | Katie Colacarro |
| Executive Vice President of Medical & Fluid Solutions | Justin Hall (age 46) |
Major Backers & Investors (NDSN)
Notable institutional backers of Nordson Corp include Kayne Anderson Rudnick Investment Management LLC, Invesco, Morgan Stanley, according to Nexqual as of June 10, 2026 at 00:50 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Kayne Anderson Rudnick Investment Management LLC | 3.67% |
| Invesco | 2.83% |
| Morgan Stanley | 2.59% |
| Massachusetts Financial Services Co. | 1.68% |
| FMR, LLC | 1.46% |
| Eaton Vance Growth Trust-Eaton Vance Atlanta Capital SMID-Cap Fund | 1.23% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 19.24% |
| BlackRock | 8.32% |
| State Street | 6.36% |
| Geode Capital | 2.77% |
Source: Nexqual, June 10, 2026 at 00:50 UTC.
From Nordson Corp's Latest SEC 10-K Filing (filed 2025-12-17)
Key Strengths & Strategy (as disclosed to the SEC)
- Nordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, medical components, and other fluids.
- The Industrial Precision Solutions segment provides dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods; automated adhesive dispensing systems; components and systems for thermoplastic and biopolymer melt stream; fluid components, such as nozzles, pumps, and filters; smart components that measure and control the flow, quantity and location of dispensed fluid; control systems; and product assembly solutions.
- It also offers automated and manual dispensing products and systems for cold materials, container coating, liquid finishing, and powder coating, as well as ultraviolet equipment.
- The Medical and Fluid Solutions segment offers precision manual and semi-automated dispensers, plastic molded syringes, cartridges, tips, and fluid connection components; interventional solutions for engineered shafts and interventional delivery systems, medical tubing, balloons, balloon inflators, nitinol devices, cardiovascular cannula, and biomaterial delivery; medical fluid components; and microplegia myocardial protection devices and related consumables.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MZTI | The Marzetti Company | USD 110.01 | ▲ 2.47% |
| SCL | Stepan Company | USD 52.4 | ▲ 2.18% |
| IEX | IDEX Corporation | USD 222.14 | ▲ 3.15% |
| DOV | Dover Corporation | USD 220.97 | ▲ 2.89% |
| FUL | H. B. Fuller Company | USD 62.03 | ▲ 3.59% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:50 UTC. This page is informational and not investment advice.